Beyond antigens and adjuvants: formulating future vaccines
The need to optimize vaccine potency while minimizing toxicity in healthy recipients has motivated studies of the formulation of vaccines to control how, when, and where antigens and adjuvants encounter immune cells and other cells/tissues following administration. An effective subunit vaccine must...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
American Society for Clinical Investigation
2017
|
| Online Access: | http://hdl.handle.net/1721.1/108232 https://orcid.org/0000-0002-0926-9642 https://orcid.org/0000-0002-9166-3891 |